awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34274254-C6E72610-245B-4B37-B07A-ECB289A2525D
Q34274254-C6E72610-245B-4B37-B07A-ECB289A2525D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34274254-C6E72610-245B-4B37-B07A-ECB289A2525D
A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension
P2860
Q34274254-C6E72610-245B-4B37-B07A-ECB289A2525D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34274254-C6E72610-245B-4B37-B07A-ECB289A2525D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f64e474c7af906106b30fbbb3211b0f32f4329fc
P2860
Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.